2024-31446Notice

Drug Agency Holds Mystery Meetings, Tells Public Nothing

Published Date: 1/2/2025

Notice

Summary

The National Institute on Drug Abuse is holding two secret virtual meetings in February 2025 to review grant applications for drug abuse research and career training. These closed meetings protect private info and trade secrets while deciding who gets funding to fight addiction and related health issues. Researchers and applicants should note these important review dates as they impact future funding opportunities.

Analyzed Economic Effects

2 provisions identified: 2 benefits, 0 costs, 0 mixed.

Feb 20 Closed Virtual Grant Review

If you applied for NIDA research grants related to delivery of pharmacological, gene editing, or other cargoes for HIV and substance use disorders, your applications will be reviewed in a closed virtual meeting on February 20, 2025, from 12:00 p.m. to 3:00 p.m. The meeting is closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets and personal information.

Feb 28 Closed Career Development Review

If you applied for NIDA career development, education, or training awards (CFDA programs 93.277, 93.278, 93.279), your applications will be reviewed in a closed virtual meeting on February 28, 2025, from 9:00 a.m. to 5:00 p.m. The meeting is closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential and personal information.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
Effective Date
1/2/2025
2/20/2025

Department and Agencies

Department
Independent Agency
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register